Indications |
Oral Hypertension Adult: 20 mg daily as a single dose or in 2 divided doses; may be increased to 20 mg bid as necessary to control resistant hypertension. Elderly: Initially, 10 mg daily. Hepatic impairment: Initially, 5-10 mg once daily. Special Populations: Patients with hepatic impairment: Initially, 10 mg daily. |
Contraindications |
Unstable angina pectoris, actue MI (<4 wk). Pregnancy and lactation. |
Warnings / Precautions |
Elderly, hepatic impairment. |
Adverse Reactions |
Hypotension, flushing, oedema, dizziness, palpitation, fatigue, headache, nausea, bloating, diarrhoea, paraesthesias, tachycardia, asthenia, drowsiness, angina, MI, irritability, respiratory disorders, hypersensitivity reactions, increased urine output, elevated LFTs, myalgia, tremor, blood count changes, gingival hyperplasia. |
Overdose Reactions |
Symptoms: Flushing, headache, BP reduction with circulatory collapse, changes in heart rate (tachycardia, bradycardia). Management: Initially, gastric lavage with subsequent activated charcoal. Dopamine or noradrenaline may be used for excessive hypotension. Atropine or orciprenaline may be used for bradycardia. |
Drug Interactions |
Effects may be enhanced by other antihypertensives. Increased sodium excretion with diuretics at the start of treatment. May prolong effects of pancuronium, vecuronium. May increase digoxin levels. Reduced levels/effects with rifampicin, phenytoin, carbamazepine or phenobarbitone. Levels/effects may be increased with cimetidine, valproic acid, erythromycin, troleandomycin, clarithromycin, roxithromycin, ketoconazole, itraconazole, fluconazole, nefazodone, protease inhibitors, quinupristin or dalfopristin. See Below for More nitrendipine Drug Interactions |
Lab Interactions |
Increases plasma catecholamine, urinary aldosterone levels and alkaline phosphatase levels. |
Food Interactions |
Concentration may be increased with grapefruit juice. |
Mechanism of Actions |
Nitrendipine relaxes coronary vascular smooth muscles by inhibiting calcium ions from entering the slow channels or select voltage-sensitive areas of vascular smooth muscles and myocardium during depolarisation. It also increases myocardial oxygen delivery in patients with vasospastic angina. Absorption: Well absorbed from the GI tract (oral). Distribution: Protein-binding: 98%. Metabolism: Extensive first-pass effect. Excretion: Via urine (as metabolites), via faeces (remaining dose); 10-22 hr (elimination half-life). |
Administration |
Should be taken with food. (Take after meals.) |
Storage Conditions |
Oral: Protect from light. |
ATC Classification |
C08CA08 - nitrendipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases. |
Storage |
Oral: Protect from light. |
Available As |
|
Nitrendipine
Post Review about Nitrendipine Click here to cancel reply.
Nitrendipine Containing Brands
Nitrendipine is used in following diseases
Drug - Drug Interactions of Nitrendipine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.